TAKEDA PHARM.SPON.ADR/1/2 (TKDA.F) Financials
TKDA.F Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 91.2 billion | 48.0 billion |
| 2023-09-30 | 94.0 billion | 49.3 billion |
| 2023-06-30 | 94.1 billion | 50.1 billion |
| 2023-03-31 | 96.4 billion | 52.5 billion |
TKDA.F Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 444.7 million | 120.0 million |
| 2023-09-30 | 814.9 million | 117.2 million |
| 2023-06-30 | -1.1 billion | 98.3 million |
| 2023-03-31 | -1.0 billion | 102.6 million |
TKDA.F Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 678.1 million |
| 2023-09-30 | -303.7 million |
| 2023-06-30 | 568.8 million |
| 2023-03-31 | 215.0 million |
TKDA.F Cash and Debt
No data available :(
TKDA.F Shares Outstanding
TKDA.F Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 494.7 million | 1.2 billion | 1.7 billion | - |
| 2023-09-30 | 239.3 million | 1.2 billion | 1.6 billion | - |
| 2023-06-30 | 240.8 million | 1.0 billion | 1.6 billion | - |
| 2023-03-31 | 261.4 million | 1.1 billion | 1.8 billion | - |
TKDA.F Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 7.1 billion | 2.4 billion |
| 2023-09-30 | 6.6 billion | 2.2 billion |
| 2023-06-30 | 6.7 billion | 2.0 billion |
| 2023-03-31 | 6.6 billion | 2.1 billion |
TKDA.F
Price: €12.10
Dividend Yield: 14.72%
Forward Dividend Yield: 0.02%
Payout Ratio: 0.69%
Dividend Per Share: 0.00 EUR
Earnings Per Share: 0.34 EUR
P/E Ratio: 33.68
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 200
Market Capitalization: 39.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 5
DGR3: -19.36%